alpha-Adrenergic Agonist [EPC]

alpha-Adrenergic Agonist [EPC] was reported 71959 times

These side effects are most commonly reported by patients taking drugs of the alpha-Adrenergic Agonist [EPC] class:

# Drug class Count
0 DRUG INEFFECTIVE 6469
1 HEADACHE 4812
2 FATIGUE 4561
3 SINUSITIS 4107
4 DYSPNOEA 3814
5 NAUSEA 3782
6 PAIN 3684
7 PRODUCT DOSE OMISSION ISSUE 3384
8 OFF LABEL USE 3250
9 PNEUMONIA 2782
10 COVID-19 2689
11 COUGH 2431
12 DIARRHOEA 2383
13 PYREXIA 2369
14 PRURITUS 2361
15 RASH 2352
16 NASOPHARYNGITIS 2305
17 DIZZINESS 2303
18 VOMITING 2250
19 MALAISE 2152
20 FALL 2100
21 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2065
22 URINARY TRACT INFECTION 2041
23 URTICARIA 1971
24 ARTHRALGIA 1956
25 WEIGHT DECREASED 1887
26 ASTHMA 1835
27 ANXIETY 1833
28 DRUG HYPERSENSITIVITY 1832
29 PRODUCT QUALITY ISSUE 1832
30 HYPOTENSION 1708
31 BRONCHITIS 1669
32 ILLNESS 1634
33 HYPERSENSITIVITY 1608
34 INJECTION SITE PAIN 1594
35 ANAPHYLACTIC REACTION 1552
36 UPPER RESPIRATORY TRACT INFECTION 1511
37 CONDITION AGGRAVATED 1507
38 PAIN IN EXTREMITY 1502
39 PRODUCT USE IN UNAPPROVED INDICATION 1499
40 INFLUENZA 1484
41 HEREDITARY ANGIOEDEMA 1432
42 INFECTION 1424
43 ASTHENIA 1400
44 BACK PAIN 1386
45 DEATH 1383
46 WEIGHT INCREASED 1367
47 DEVICE FAILURE 1366
48 BLOOD PRESSURE INCREASED 1279
49 INFUSION RELATED REACTION 1248
50 PRODUCT USE ISSUE 1236
51 CHEST PAIN 1176
52 MIGRAINE 1164
53 HYPERTENSION 1145
54 ERYTHEMA 1093
55 FEELING ABNORMAL 1091
56 ACCIDENTAL EXPOSURE TO PRODUCT 1073
57 EAR INFECTION 1049
58 CARDIAC ARREST 1003
59 CHILLS 971
60 INSURANCE ISSUE 968
61 HEART RATE INCREASED 961
62 DEPRESSION 959
63 ABDOMINAL PAIN 958
64 INSOMNIA 957
65 CHEST DISCOMFORT 955
66 STRESS 948
67 INFUSION SITE PAIN 920
68 INTENTIONAL PRODUCT USE ISSUE 889
69 RESPIRATORY TRACT INFECTION 881
70 SOMNOLENCE 875
71 PERIPHERAL SWELLING 873
72 TREMOR 867
73 OROPHARYNGEAL PAIN 866
74 RENAL FAILURE 853
75 CONTUSION 852
76 MUSCLE SPASMS 848
77 TACHYCARDIA 848
78 ABDOMINAL PAIN UPPER 826
79 PALPITATIONS 818
80 SEASONAL ALLERGY 805
81 SWELLING 784
82 ABDOMINAL DISCOMFORT 763
83 HYPOAESTHESIA 756
84 LOSS OF CONSCIOUSNESS 753
85 WHEEZING 730
86 INCORRECT DOSE ADMINISTERED 729
87 UNEVALUABLE EVENT 729
88 PARAESTHESIA 717
89 NASAL CONGESTION 707
90 DECREASED APPETITE 705
91 NO ADVERSE EVENT 693
92 DEHYDRATION 691
93 TOXICITY TO VARIOUS AGENTS 691
94 VIRAL INFECTION 691
95 CONSTIPATION 684
96 LIQUID PRODUCT PHYSICAL ISSUE 678
97 GAIT DISTURBANCE 672
98 INFUSION SITE SWELLING 671
99 MYALGIA 662
100 SEPSIS 656
101 INJURY 648
102 MULTIPLE ALLERGIES 642
103 SEIZURE 636
104 INFUSION SITE ERYTHEMA 629
105 PRODUCTIVE COUGH 628
106 MUSCULAR WEAKNESS 625
107 INJECTION SITE ERYTHEMA 623
108 BRADYCARDIA 614
109 NEEDLE ISSUE 608
110 HYPERHIDROSIS 599
111 CEREBROVASCULAR ACCIDENT 580
112 ANGIOEDEMA 578
113 ACUTE KIDNEY INJURY 576
114 ABDOMINAL DISTENSION 567
115 INFLUENZA LIKE ILLNESS 566
116 GASTROINTESTINAL DISORDER 553
117 OVERDOSE 553
118 FLUSHING 551
119 ATRIAL FIBRILLATION 549
120 MEMORY IMPAIRMENT 548
121 RHINORRHOEA 548
122 INJECTION SITE SWELLING 543
123 DYSPHAGIA 541
124 ANAEMIA 540
125 HOSPITALISATION 528
126 CONFUSIONAL STATE 523
127 EMOTIONAL DISTRESS 522
128 ARTHRITIS 516
129 GASTROENTERITIS VIRAL 506
130 OXYGEN SATURATION DECREASED 505
131 VISION BLURRED 499
132 BLOOD PRESSURE DECREASED 497
133 SYNCOPE 497
134 SWELLING FACE 494
135 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 493
136 GASTROOESOPHAGEAL REFLUX DISEASE 493
137 MATERNAL EXPOSURE DURING PREGNANCY 488
138 DRY SKIN 480
139 INFUSION SITE EXTRAVASATION 478
140 POOR VENOUS ACCESS 477
141 SWOLLEN TONGUE 476
142 CARDIAC DISORDER 473
143 FEAR 461
144 OEDEMA PERIPHERAL 460
145 INFUSION SITE PRURITUS 458
146 THROMBOSIS 458
147 RESPIRATORY FAILURE 457
148 MYOCARDIAL INFARCTION 456
149 DRUG INTERACTION 454
150 ECZEMA 454
151 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 451
152 PHARYNGEAL SWELLING 444
153 ALOPECIA 441
154 THROAT IRRITATION 441
155 RENAL IMPAIRMENT 440
156 CELLULITIS 438
157 CYSTITIS 438
158 INJECTION SITE BRUISING 432
159 NEUROPATHY PERIPHERAL 432
160 FUNGAL INFECTION 431
161 JOINT SWELLING 426
162 PULMONARY EMBOLISM 424
163 BURNING SENSATION 420
164 VERTIGO 419
165 SLEEP DISORDER 411
166 NEPHROLITHIASIS 408
167 STRESS CARDIOMYOPATHY 404
168 DERMATITIS ATOPIC 400
169 DERMATITIS CONTACT 399
170 HERPES ZOSTER 395
171 LIP SWELLING 395
172 NECK PAIN 395
173 SINUS DISORDER 391
174 ACCIDENTAL EXPOSURE 390
175 INFUSION SITE HAEMORRHAGE 385
176 DYSPHONIA 382
177 EXPIRED PRODUCT ADMINISTERED 381
178 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 380
179 RENAL INJURY 379
180 INJECTION SITE HAEMORRHAGE 377
181 IMPAIRED QUALITY OF LIFE 376
182 DEVICE ISSUE 374
183 BALANCE DISORDER 373
184 CARDIOGENIC SHOCK 371
185 HAEMORRHAGE 370
186 THROAT TIGHTNESS 368
187 VISUAL IMPAIRMENT 368
188 ANAPHYLACTIC SHOCK 366
189 STAPHYLOCOCCAL INFECTION 364
190 CATARACT 363
191 DISCOMFORT 361
192 FEELING HOT 359
193 KIDNEY INFECTION 355
194 LIMB INJURY 355
195 HYPOXIA 352
196 INJECTION SITE PRURITUS 352
197 EPISTAXIS 348
198 DRUG DOSE OMISSION 347
199 METABOLIC ACIDOSIS 347
200 DEVICE MALFUNCTION 344
201 INFUSION SITE DISCHARGE 341
202 OEDEMA 339
203 DYSPEPSIA 338
204 THERAPY INTERRUPTED 333
205 ANHEDONIA 328
206 PULMONARY OEDEMA 328
207 INFUSION SITE BRUISING 326
208 LOCALISED INFECTION 325
209 HAEMOGLOBIN DECREASED 324
210 EXPOSURE DURING PREGNANCY 322
211 INTENTIONAL OVERDOSE 322
212 PHARYNGITIS STREPTOCOCCAL 315
213 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 313
214 SKIN EXFOLIATION 310
215 BLOOD GLUCOSE INCREASED 306
216 RASH PRURITIC 306
217 CHRONIC KIDNEY DISEASE 304
218 INJECTION SITE REACTION 303
219 DEEP VEIN THROMBOSIS 300
220 TOOTH INFECTION 298
221 MUSCULOSKELETAL STIFFNESS 295
222 DRY EYE 290
223 VENTRICULAR TACHYCARDIA 289
224 DYSPNOEA EXERTIONAL 287
225 DRY MOUTH 286
226 PRODUCT DOSE OMISSION IN ERROR 286
227 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 285
228 TINNITUS 285
229 INCORRECT DRUG ADMINISTRATION RATE 284
230 ADVERSE DRUG REACTION 283
231 SHOCK 283
232 THERAPY NON-RESPONDER 283
233 RESPIRATORY DISORDER 282
234 SURGERY 281
235 PRODUCT DISTRIBUTION ISSUE 279
236 LETHARGY 278
237 MULTI-ORGAN FAILURE 278
238 RHEUMATOID ARTHRITIS 277
239 EYE SWELLING 275
240 LUNG DISORDER 275
241 HEART RATE DECREASED 273
242 LACTIC ACIDOSIS 273
243 RESPIRATORY DISTRESS 271
244 CARDIAC FAILURE CONGESTIVE 268
245 FOOD ALLERGY 266
246 HEAD INJURY 266
247 LOWER RESPIRATORY TRACT INFECTION 266
248 SKIN INFECTION 264
249 INJURY ASSOCIATED WITH DEVICE 259
250 THERAPEUTIC RESPONSE DECREASED 259
251 SPEECH DISORDER 256
252 ROAD TRAFFIC ACCIDENT 255
253 EYE INFECTION 253
254 DIABETES MELLITUS 251
255 SKIN DISCOLOURATION 251
256 WEIGHT FLUCTUATION 251
257 MEDICATION ERROR 250
258 EYE PAIN 249
259 HOT FLUSH 247
260 RASH ERYTHEMATOUS 247
261 EYE IRRITATION 246
262 COMA 245
263 RESPIRATORY TRACT CONGESTION 245
264 POST PROCEDURAL COMPLICATION 244
265 DIVERTICULITIS 243
266 GENERAL PHYSICAL HEALTH DETERIORATION 243
267 HAEMATOCHEZIA 243
268 THROMBOCYTOPENIA 243
269 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 242
270 RHINITIS 241
271 AGITATION 239
272 ARRHYTHMIA 239
273 NERVOUSNESS 237
274 BACTERIAL INFECTION 236
275 BRAIN FOG 236
276 BLISTER 235
277 SEPTIC SHOCK 235
278 ACCIDENTAL OVERDOSE 234
279 FLUID RETENTION 233
280 SINUS CONGESTION 232
281 DRUG INTOLERANCE 231
282 PLEURAL EFFUSION 231
283 EYE PRURITUS 230
284 CANDIDA INFECTION 229
285 CARDIO-RESPIRATORY ARREST 228
286 PSORIASIS 227
287 BLOOD PRESSURE ABNORMAL 226
288 SKIN LACERATION 226
289 SUICIDAL IDEATION 226
290 PLATELET COUNT DECREASED 225
291 LACRIMATION INCREASED 223
292 JOINT INJURY 220
293 LYMPHADENOPATHY 218
294 INTENTIONAL PRODUCT MISUSE 214
295 UNDERDOSE 214
296 PANIC ATTACK 213
297 WHITE BLOOD CELL COUNT DECREASED 213
298 DYSGEUSIA 212
299 DRUG DOSE OMISSION BY DEVICE 211
300 MULTIPLE ORGAN DYSFUNCTION SYNDROME 211
301 OCULAR HYPERAEMIA 211
302 SYSTEMIC LUPUS ERYTHEMATOSUS 210
303 SNEEZING 209
304 BONE PAIN 206
305 MOBILITY DECREASED 205
306 OSTEOPOROSIS 205
307 GASTROINTESTINAL HAEMORRHAGE 204
308 RASH MACULAR 204
309 ELECTROCARDIOGRAM QT PROLONGED 203
310 CARDIAC FAILURE 202
311 DEPRESSED MOOD 202
312 EAR PAIN 202
313 FOOT FRACTURE 201
314 VENTRICULAR FIBRILLATION 201
315 SINUS TACHYCARDIA 200
316 PHARYNGITIS 198
317 HEPATIC ENZYME INCREASED 197
318 BLOOD POTASSIUM DECREASED 196
319 COLITIS ULCERATIVE 196
320 CROHN^S DISEASE 196
321 FOETAL EXPOSURE DURING PREGNANCY 196
322 HYPOKALAEMIA 196
323 PHARYNGEAL OEDEMA 196
324 BRONCHOSPASM 193
325 NEOPLASM MALIGNANT 192
326 RECTAL HAEMORRHAGE 192
327 AMNESIA 190
328 WHITE BLOOD CELL COUNT INCREASED 190
329 ACUTE MYOCARDIAL INFARCTION 189
330 FIBROMYALGIA 189
331 PALLOR 189
332 UNRESPONSIVE TO STIMULI 188
333 FEELING COLD 187
334 INFLAMMATION 187
335 INTENTIONAL DOSE OMISSION 186
336 DEVICE USE ISSUE 185
337 GASTROINTESTINAL INFECTION 185
338 RENAL DISORDER 184
339 SCAR 184
340 CLOSTRIDIUM DIFFICILE INFECTION 183
341 PRODUCT STORAGE ERROR 183
342 LIMB DISCOMFORT 182
343 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 181
344 BLOOD CREATININE INCREASED 181
345 FREQUENT BOWEL MOVEMENTS 180
346 ILL-DEFINED DISORDER 180
347 MENTAL DISORDER 180
348 NEURALGIA 180
349 DEPRESSED LEVEL OF CONSCIOUSNESS 177
350 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 177
351 INFUSION SITE MASS 177
352 SLEEP APNOEA SYNDROME 175
353 PANCREATITIS 173
354 MUSCULOSKELETAL PAIN 172
355 PARAESTHESIA ORAL 172
356 RENAL FAILURE ACUTE 172
357 ARTHROPATHY 171
358 DEVICE RELATED INFECTION 171
359 PROCEDURAL PAIN 171
360 RESPIRATORY SYNCYTIAL VIRUS INFECTION 171
361 CONJUNCTIVITIS 170
362 TENDERNESS 170
363 HYPERSOMNIA 169
364 TOOTH ABSCESS 169
365 DISTURBANCE IN ATTENTION 168
366 NEUTROPENIA 168
367 OSTEOARTHRITIS 168
368 BLOOD PRESSURE SYSTOLIC INCREASED 167
369 DYSURIA 167
370 BODY TEMPERATURE INCREASED 166
371 DYSARTHRIA 166
372 IRRITABILITY 166
373 INTESTINAL OBSTRUCTION 165
374 UPPER-AIRWAY COUGH SYNDROME 165
375 ORAL HERPES 164
376 COGNITIVE DISORDER 163
377 BLOOD PRESSURE FLUCTUATION 162
378 CIRCULATORY COLLAPSE 162
379 PRODUCT AVAILABILITY ISSUE 162
380 THERAPEUTIC RESPONSE SHORTENED 162
381 DEVICE LEAKAGE 161
382 EXPIRED DRUG ADMINISTERED 160
383 COLITIS 158
384 COVID-19 PNEUMONIA 158
385 NIGHTMARE 158
386 THERAPEUTIC RESPONSE UNEXPECTED 158
387 ACUTE RESPIRATORY DISTRESS SYNDROME 157
388 DISEASE PROGRESSION 157
389 HAEMODYNAMIC INSTABILITY 157
390 TREATMENT FAILURE 156
391 RIB FRACTURE 155
392 STOMATITIS 154
393 ARTHROPOD BITE 153
394 INJECTION SITE MASS 153
395 THERAPEUTIC PRODUCT EFFECT DECREASED 153
396 MIDDLE INSOMNIA 152
397 PNEUMONIA ASPIRATION 152
398 POLLAKIURIA 152
399 PULSELESS ELECTRICAL ACTIVITY 152
400 WOUND 152
401 IMPAIRED WORK ABILITY 151
402 MUSCULOSKELETAL DISCOMFORT 151
403 PRODUCT COLOUR ISSUE 151
404 LIGAMENT SPRAIN 150
405 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 150
406 BRONCHIECTASIS 148
407 INJECTION SITE RASH 148
408 DEVICE INFUSION ISSUE 147
409 OBSTRUCTIVE AIRWAYS DISORDER 147
410 POOR QUALITY SLEEP 147
411 TRANSIENT ISCHAEMIC ATTACK 147
412 TREATMENT NONCOMPLIANCE 147
413 INFUSION SITE RASH 146
414 MENTAL STATUS CHANGES 146
415 INFUSION SITE REACTION 145
416 FEBRILE NEUTROPENIA 144
417 FLATULENCE 144
418 HAEMOPTYSIS 144
419 OBSTRUCTION 144
420 HERNIA 143
421 EYE DISORDER 142
422 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 141
423 PREMATURE BABY 141
424 PRODUCT ADMINISTRATION INTERRUPTED 141
425 ACUTE RESPIRATORY FAILURE 140
426 BLOOD GLUCOSE DECREASED 140
427 NERVOUS SYSTEM DISORDER 140
428 RED BLOOD CELL COUNT DECREASED 140
429 STREPTOCOCCAL INFECTION 140
430 CARDIAC MURMUR 139
431 FEELING JITTERY 139
432 HIP FRACTURE 139
433 KOUNIS SYNDROME 139
434 CRYING 138
435 INJECTION SITE URTICARIA 138
436 HYPERKALAEMIA 137
437 SKIN BURNING SENSATION 137
438 SKIN DISORDER 137
439 SUICIDE ATTEMPT 137
440 INTERVERTEBRAL DISC PROTRUSION 136
441 CHRONIC SINUSITIS 135
442 ARTERIOSPASM CORONARY 134
443 ALANINE AMINOTRANSFERASE INCREASED 132
444 PRESYNCOPE 132
445 PRODUCT DOSE OMISSION 132
446 ANKLE FRACTURE 131
447 ACNE 130
448 DIPLOPIA 130
449 HAEMATOMA 130
450 PNEUMOTHORAX 130
451 CYANOSIS 129
452 INJECTION SITE DISCOLOURATION 129
453 NIGHT SWEATS 129
454 PSEUDOMONAS INFECTION 129
455 HYPOGLYCAEMIA 127
456 INJECTION SITE PALLOR 127
457 MULTIPLE SCLEROSIS 127
458 SKIN CANCER 127
459 ASPARTATE AMINOTRANSFERASE INCREASED 126
460 PRODUCT PRESCRIBING ISSUE 126
461 RHABDOMYOLYSIS 126
462 HEART RATE IRREGULAR 125
463 PAIN IN JAW 125
464 ADVERSE EVENT 124
465 INCORRECT ROUTE OF DRUG ADMINISTRATION 124
466 PULMONARY HYPERTENSION 124
467 PULMONARY MASS 124
468 POST PROCEDURAL INFECTION 123
469 SKIN IRRITATION 123
470 PAROSMIA 122
471 THERAPY CESSATION 122
472 APHONIA 121
473 BACK DISORDER 121
474 CONCUSSION 121
475 GAIT INABILITY 121
476 GASTRITIS 121
477 ORAL CANDIDIASIS 121
478 SCRATCH 121
479 UPPER LIMB FRACTURE 121
480 GENERALISED TONIC-CLONIC SEIZURE 120
481 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 120
482 OSTEOMYELITIS 120
483 CHOLELITHIASIS 119
484 MUSCLE TIGHTNESS 119
485 MYOCARDIAL ISCHAEMIA 119
486 PRODUCT SUBSTITUTION ISSUE 119
487 HYPOAESTHESIA ORAL 118
488 LARYNGITIS 118
489 PRESCRIBED OVERDOSE 118
490 VITAMIN D DEFICIENCY 118
491 COAGULOPATHY 117
492 MUSCULOSKELETAL CHEST PAIN 117
493 MYASTHENIA GRAVIS 117
494 BLINDNESS 116
495 BREAST CANCER 116
496 IMPAIRED GASTRIC EMPTYING 116
497 BLOOD SODIUM DECREASED 115
498 CARPAL TUNNEL SYNDROME 115
499 INJECTION SITE INJURY 114
500 SKIN ABRASION 114
501 SKIN LESION 114
502 WRIST FRACTURE 114
503 PRODUCT ADMINISTRATION ERROR 113
504 EATING DISORDER 112
505 FEEDING DISORDER 112
506 HEAD DISCOMFORT 112
507 PARALYSIS 112
508 PREGNANCY 112
509 SARS-COV-2 TEST POSITIVE 112
510 BLOOD CHOLESTEROL INCREASED 111
511 HYPOPNOEA 111
512 TOOTH DISORDER 111
513 ULCER 111
514 DEVICE BREAKAGE 110
515 DRUG EFFECT INCOMPLETE 110
516 ELECTROCARDIOGRAM ABNORMAL 110
517 HALLUCINATION 109
518 TYPE 2 DIABETES MELLITUS 109
519 APHASIA 108
520 RASH PAPULAR 108
521 SPINAL FRACTURE 108
522 SPUTUM DISCOLOURED 108
523 EJECTION FRACTION DECREASED 107
524 HYPERGLYCAEMIA 107
525 PERICARDIAL EFFUSION 107
526 SKIN FISSURES 107
527 FOOD POISONING 106
528 IMPAIRED HEALING 106
529 IRRITABLE BOWEL SYNDROME 106
530 MULTIPLE SCLEROSIS RELAPSE 106
531 SECRETION DISCHARGE 106
532 SUPRAVENTRICULAR TACHYCARDIA 106
533 MASS 105
534 PRE-EXISTING CONDITION IMPROVED 105
535 PREMATURE DELIVERY 105
536 RESTLESS LEGS SYNDROME 105
537 TOOTHACHE 105
538 DISORIENTATION 104
539 EMOTIONAL DISORDER 104
540 LUNG INFECTION 104
541 TUBULOINTERSTITIAL NEPHRITIS 104
542 WOUND INFECTION 104
543 DEVICE OCCLUSION 103
544 HYPOPHAGIA 103
545 PARANASAL SINUS DISCOMFORT 103
546 VENTRICULAR EXTRASYSTOLES 103
547 DRUG ADMINISTRATION ERROR 102
548 DYSKINESIA 102
549 BRAIN INJURY 101
550 CONVULSION 101
551 GINGIVAL PAIN 101
552 INFUSION SITE DISCOMFORT 101
553 PNEUMONIA BACTERIAL 101
554 URINARY RETENTION 101
555 BODY HEIGHT DECREASED 100
556 HYPOACUSIS 100
557 INABILITY TO AFFORD MEDICATION 100
558 LOWER LIMB FRACTURE 100
559 OROPHARYNGEAL DISCOMFORT 100
560 CHOKING 99
561 COLD SWEAT 99
562 COMPLICATION ASSOCIATED WITH DEVICE 99
563 HEPATIC FAILURE 99
564 PERIPHERAL ISCHAEMIA 99
565 SPINAL OPERATION 99
566 VASCULAR ACCESS SITE COMPLICATION 99
567 CARDIOMYOPATHY 97
568 LIVER DISORDER 97
569 PHOTOPHOBIA 97
570 POST-TRAUMATIC STRESS DISORDER 97
571 RESTLESSNESS 97
572 SENSITIVE SKIN 97
573 TOXIC ANTERIOR SEGMENT SYNDROME 97
574 VASOPLEGIA SYNDROME 97
575 WRONG TECHNIQUE IN DRUG USAGE PROCESS 97
576 ANGER 96
577 HAEMORRHOIDS 96
578 RETCHING 96
579 VASCULAR DEVICE INFECTION 96
580 BLOOD LACTIC ACID INCREASED 95
581 TEMPERATURE INTOLERANCE 95
582 APLASTIC ANAEMIA 94
583 HIATUS HERNIA 94
584 LARYNGEAL OEDEMA 94
585 PRODUCT USE COMPLAINT 94
586 RESPIRATORY ARREST 94
587 ROTATOR CUFF SYNDROME 94
588 TACHYPNOEA 94
589 BLOOD UREA INCREASED 93
590 CARDIOTOXICITY 93
591 EXPOSURE VIA SKIN CONTACT 93
592 GASTRIC DISORDER 93
593 INFUSION SITE URTICARIA 93
594 MUSCLE STRAIN 93
595 PULMONARY CONGESTION 93
596 C-REACTIVE PROTEIN INCREASED 92
597 CEREBRAL HAEMORRHAGE 92
598 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 92
599 HAEMATEMESIS 92
600 PSORIATIC ARTHROPATHY 92
601 RESPIRATORY DEPRESSION 92
602 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 92
603 AUTOIMMUNE DISORDER 91
604 CENTRAL VENOUS CATHETERISATION 91
605 GALLBLADDER DISORDER 91
606 MAST CELL ACTIVATION SYNDROME 91
607 THYROID DISORDER 91
608 AGGRESSION 90
609 ATELECTASIS 90
610 DRUG EFFECT DECREASED 90
611 DYSSTASIA 90
612 HYPONATRAEMIA 90
613 HYPOTHYROIDISM 90
614 MENINGITIS ASEPTIC 90
615 MOVEMENT DISORDER 90
616 SINUS BRADYCARDIA 90
617 INCORRECT PRODUCT ADMINISTRATION DURATION 89
618 JOINT STIFFNESS 89
619 URINARY INCONTINENCE 89
620 BLOOD PRESSURE DIASTOLIC DECREASED 88
621 BRAIN OEDEMA 88
622 KNEE ARTHROPLASTY 88
623 MYDRIASIS 88
624 ABSCESS 87
625 BLOOD IRON DECREASED 87
626 BURNS SECOND DEGREE 87
627 DERMATITIS 87
628 FLANK PAIN 87
629 HAEMATOCRIT DECREASED 87
630 SKIN ULCER 87
631 ACIDOSIS 86
632 ADMINISTRATION SITE PAIN 86
633 ENCEPHALOPATHY 86
634 INFUSION SITE NODULE 86
635 BODY TEMPERATURE DECREASED 85
636 DELIRIUM 85
637 DEVICE DIFFICULT TO USE 85
638 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 85
639 LEUKOCYTOSIS 85
640 SKIN HAEMORRHAGE 85
641 EMPHYSEMA 84
642 GOUT 84
643 HAND FRACTURE 84
644 INFUSION SITE IRRITATION 84
645 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 83
646 HORDEOLUM 83
647 INJECTION SITE HYPOAESTHESIA 83
648 INJECTION SITE WARMTH 83
649 PULMONARY THROMBOSIS 83
650 ABNORMAL BEHAVIOUR 82
651 ADRENAL INSUFFICIENCY 82
652 CYST 82
653 HEPATIC STEATOSIS 82
654 MITRAL VALVE INCOMPETENCE 82
655 NASAL DISCOMFORT 82
656 PHARMACEUTICAL PRODUCT COMPLAINT 82
657 RESPIRATORY ACIDOSIS 82
658 SCIATICA 82
659 ARTHROPOD STING 81
660 DISABILITY 81
661 DRUG EFFECT LESS THAN EXPECTED 81
662 ESCHERICHIA INFECTION 81
663 FACIAL PAIN 81
664 NERVE COMPRESSION 81
665 RHINOVIRUS INFECTION 81
666 DECREASED ACTIVITY 80
667 DISSEMINATED INTRAVASCULAR COAGULATION 80
668 EXTRA DOSE ADMINISTERED 80
669 HYPERAESTHESIA 80
670 MOUTH SWELLING 80
671 ORAL PAIN 80
672 SEROTONIN SYNDROME 80
673 SPINAL DISORDER 80
674 TOOTH FRACTURE 80
675 VISUAL ACUITY REDUCED 80
676 ANAESTHETIC COMPLICATION 79
677 CATARRH 79
678 FEMUR FRACTURE 79
679 LIVE BIRTH 79
680 OBESITY 79
681 PANCYTOPENIA 79
682 PULSE ABSENT 79
683 RHINITIS ALLERGIC 79
684 STEROID DEPENDENCE 79
685 THERMAL BURN 79
686 CORONARY ARTERY DISEASE 78
687 DISTRIBUTIVE SHOCK 78
688 ECONOMIC PROBLEM 78
689 FACIAL PARALYSIS 78
690 PHOTOSENSITIVITY REACTION 78
691 QUALITY OF LIFE DECREASED 78
692 TROPONIN INCREASED 78
693 DRUG DEPENDENCE 77
694 RESPIRATORY RATE INCREASED 77
695 BLOOD URINE PRESENT 76
696 CHROMATURIA 76
697 DEAFNESS 76
698 EAR DISCOMFORT 76
699 EYELID PTOSIS 76
700 INJECTION SITE EXTRAVASATION 76
701 MUSCLE TWITCHING 76
702 ABDOMINAL PAIN LOWER 75
703 ANIMAL BITE 75
704 GLAUCOMA 75
705 IMMUNE SYSTEM DISORDER 75
706 LABORATORY TEST ABNORMAL 75
707 LYME DISEASE 75
708 MATERNAL EXPOSURE DURING DELIVERY 75
709 PERIPHERAL COLDNESS 75
710 ASPIRATION 74
711 INFUSION SITE WARMTH 74
712 PRURITUS GENERALISED 74
713 SCAB 74
714 WITHDRAWAL SYNDROME 74
715 CATHETER SITE PAIN 73
716 END STAGE RENAL DISEASE 73
717 MALIGNANT NEOPLASM PROGRESSION 73
718 VITAMIN D DECREASED 73
719 BLOOD ALKALINE PHOSPHATASE INCREASED 72
720 LEFT VENTRICULAR DYSFUNCTION 72
721 RALES 72
722 ABORTION SPONTANEOUS 71
723 GENERALISED OEDEMA 71
724 LOCAL SWELLING 71
725 THIRST 71
726 ANGINA PECTORIS 70
727 BACTERAEMIA 70
728 BURSITIS 70
729 DEVICE DEFECTIVE 70
730 DRUG EXPOSURE DURING PREGNANCY 70
731 EYE INFLAMMATION 70
732 FAECES DISCOLOURED 70
733 GLYCOSYLATED HAEMOGLOBIN INCREASED 70
734 INJECTION SITE HAEMATOMA 70
735 MENTAL IMPAIRMENT 70
736 STRIDOR 70
737 COORDINATION ABNORMAL 69
738 HYPERLACTACIDAEMIA 69
739 INTERVERTEBRAL DISC DEGENERATION 69
740 PAIN OF SKIN 69
741 SMALL INTESTINAL OBSTRUCTION 69
742 FULL BLOOD COUNT ABNORMAL 68
743 HYPERLIPIDAEMIA 68
744 INJECTION SITE LACERATION 68
745 MOOD SWINGS 68
746 POST PROCEDURAL HAEMORRHAGE 68
747 POSTOPERATIVE WOUND INFECTION 68
748 RASH GENERALISED 68
749 TASTE DISORDER 68
750 VEIN DISORDER 68
751 DEVICE DISLOCATION 67
752 HEART RATE ABNORMAL 67
753 HYPOKINESIA 67
754 PNEUMONITIS 67
755 RESPIRATORY TRACT INFECTION VIRAL 67
756 SINUS HEADACHE 67
757 BACK INJURY 66
758 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 66
759 CARDIOMEGALY 66
760 ENDOPHTHALMITIS 66
761 GASTRIC INFECTION 66
762 RESPIRATION ABNORMAL 66
763 ASCITES 65
764 ATRIAL FLUTTER 65
765 DRUG ABUSE 65
766 INJECTION SITE DISCOMFORT 65
767 PRODUCT COMPLAINT 65
768 PULMONARY HAEMORRHAGE 65
769 TENDONITIS 65
770 TOOTH EXTRACTION 65
771 VENTRICULAR HYPOKINESIA 65
772 ANURIA 64
773 BLOOD POTASSIUM INCREASED 64
774 BONE DISORDER 64
775 FACE OEDEMA 64
776 HAEMATURIA 64
777 HYPERVOLAEMIA 64
778 ISCHAEMIA 64
779 NERVE INJURY 64
780 NODULE 64
781 PRODUCT PREPARATION ERROR 64
782 SUSPECTED COVID-19 64
783 URINE OUTPUT DECREASED 64
784 BLADDER DISORDER 63
785 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 63
786 IMMUNODEFICIENCY 63
787 INJECTION SITE COLDNESS 63
788 LOW BIRTH WEIGHT BABY 63
789 OCULAR DISCOMFORT 63
790 SEDATION 63
791 THERAPY CHANGE 63
792 APNOEA 62
793 DEVICE DELIVERY SYSTEM ISSUE 62
794 DRUG WITHDRAWAL SYNDROME 62
795 LYMPHOCYTE COUNT DECREASED 62
796 LYMPHOMA 62
797 MOOD ALTERED 62
798 NEUTROPHIL COUNT DECREASED 62
799 NEUTROPHIL COUNT INCREASED 62
800 ORAL INFECTION 62
801 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 62
802 VENTRICULAR ARRHYTHMIA 62
803 VITAMIN B12 DEFICIENCY 62
804 ADMINISTRATION SITE SWELLING 61
805 BASAL CELL CARCINOMA 61
806 BLOOD BILIRUBIN INCREASED 61
807 BLOOD MAGNESIUM DECREASED 61
808 BLOOD PRESSURE SYSTOLIC DECREASED 61
809 HYPERCAPNIA 61
810 JOINT DISLOCATION 61
811 OXYGEN SATURATION ABNORMAL 61
812 PARANASAL SINUS HYPERSECRETION 61
813 ARTHRITIS INFECTIVE 60
814 BODY TEMPERATURE ABNORMAL 60
815 DECUBITUS ULCER 60
816 ELECTROLYTE IMBALANCE 60
817 NO DEVICE MALFUNCTION 60
818 SENSITIVITY TO WEATHER CHANGE 60
819 STATUS EPILEPTICUS 60
820 WRONG DRUG ADMINISTERED 60
821 GASTRIC ULCER 59
822 LEUKOPENIA 59
823 ACCIDENT 58
824 BIPOLAR DISORDER 58
825 BLOOD CREATINE PHOSPHOKINASE INCREASED 58
826 BLOOD TEST ABNORMAL 58
827 BREATH SOUNDS ABNORMAL 58
828 LIVER FUNCTION TEST ABNORMAL 58
829 NEPHROGENIC ANAEMIA 58
830 NORMAL NEWBORN 58
831 OSTEOPENIA 58
832 INJECTION SITE IRRITATION 57
833 PSYCHOTIC DISORDER 57
834 SENSATION OF FOREIGN BODY 57
835 SJOGREN^S SYNDROME 57
836 SKELETAL INJURY 57
837 TORSADE DE POINTES 57
838 ABNORMAL DREAMS 56
839 EYE DISCHARGE 56
840 FULL BLOOD COUNT DECREASED 56
841 HEMIPARESIS 56
842 KNEE OPERATION 56
843 LAGOPHTHALMOS 56
844 RED BLOOD CELL SEDIMENTATION RATE INCREASED 56
845 RENAL TUBULAR NECROSIS 56
846 VEIN RUPTURE 56
847 BLOOD CALCIUM DECREASED 55
848 FORCED EXPIRATORY VOLUME DECREASED 55
849 GASTROINTESTINAL PAIN 55
850 HYPOTHERMIA 55
851 HYSTERECTOMY 55
852 INFUSION SITE INDURATION 55
853 INJECTION SITE INDURATION 55
854 INTERNATIONAL NORMALISED RATIO INCREASED 55
855 NOROVIRUS INFECTION 55
856 ACUTE PULMONARY OEDEMA 54
857 ATRIOVENTRICULAR BLOCK 54
858 BLOOD GLUCOSE ABNORMAL 54
859 CHOLECYSTECTOMY 54
860 COMPARTMENT SYNDROME 54
861 DEMENTIA 54
862 GINGIVITIS 54
863 INJECTION SITE DISCHARGE 54
864 INTRAOCULAR PRESSURE INCREASED 54
865 IRON DEFICIENCY ANAEMIA 54
866 PELVIC PAIN 54
867 PERIORBITAL SWELLING 54
868 PLASMA CELL MYELOMA 54
869 SKIN REACTION 54
870 AGEUSIA 53
871 BLOOD TRIGLYCERIDES INCREASED 53
872 EAR DISORDER 53
873 FURUNCLE 53
874 INFUSION SITE DISCOLOURATION 53
875 NEOPLASM 53
876 OSTEONECROSIS 53
877 PULMONARY FIBROSIS 53
878 SKIN SWELLING 53
879 SYRINGE ISSUE 53
880 VAGINAL HAEMORRHAGE 53
881 ANAL INCONTINENCE 52
882 BLOOD IMMUNOGLOBULIN E INCREASED 52
883 EOSINOPHIL COUNT INCREASED 52
884 EXOSTOSIS 52
885 EYELID OEDEMA 52
886 FLUID OVERLOAD 52
887 HYPERTENSIVE CRISIS 52
888 MACULAR DEGENERATION 52
889 PLEURISY 52
890 UPPER GASTROINTESTINAL HAEMORRHAGE 52
891 ACUTE CORONARY SYNDROME 51
892 ALLERGIC SINUSITIS 51
893 BLOOD IMMUNOGLOBULIN G DECREASED 51
894 COMPLETED SUICIDE 51
895 FEAR OF INJECTION 51
896 HEPARIN-INDUCED THROMBOCYTOPENIA 51
897 INCORRECT DOSE ADMINISTERED BY DEVICE 51
898 INFUSION SITE SCAR 51
899 INTERSTITIAL LUNG DISEASE 51
900 MUCOSAL INFLAMMATION 51
901 NASAL DISCHARGE DISCOLOURATION 51
902 NASAL POLYPS 51
903 PRODUCT DISPENSING ERROR 51
904 PRODUCT LABEL ISSUE 51
905 PSYCHOMOTOR HYPERACTIVITY 51
906 SENSORY DISTURBANCE 51
907 ALTERED STATE OF CONSCIOUSNESS 50
908 DERMATITIS ALLERGIC 50
909 FRACTURE 50
910 HIP ARTHROPLASTY 50
911 INTESTINAL ISCHAEMIA 50
912 LUNG NEOPLASM MALIGNANT 50
913 MENINGITIS 50
914 MIDDLE EAR EFFUSION 50
915 PANCREATITIS ACUTE 50
916 PROCEDURAL COMPLICATION 50
917 PRODUCT PACKAGING ISSUE 50
918 SWELLING OF EYELID 50
919 WALKING AID USER 50
920 DENTAL CARIES 49
921 GASTROENTERITIS 49
922 MICTURITION URGENCY 49
923 NEUROTOXICITY 49
924 PRODUCT PACKAGING CONFUSION 49
925 SUSPECTED OFF LABEL USE 49
926 TENDON RUPTURE 49
927 TRICUSPID VALVE INCOMPETENCE 49
928 VITREOUS FLOATERS 49
929 WRONG PRODUCT ADMINISTERED 49
930 ASPERGILLUS INFECTION 48
931 ATYPICAL PNEUMONIA 48
932 DISEASE RECURRENCE 48
933 IMMUNISATION REACTION 48
934 MOUTH ULCERATION 48
935 ORAL PRURITUS 48
936 PRODUCT PREPARATION ISSUE 48
937 RESTRICTIVE PULMONARY DISEASE 48
938 SCOLIOSIS 48
939 THROAT CLEARING 48
940 VASOCONSTRICTION 48
941 ADVERSE REACTION 47
942 CYTOKINE RELEASE SYNDROME 47
943 EXTREMITY NECROSIS 47
944 HEPATIC CIRRHOSIS 47
945 HEPATITIS 47
946 HORNER^S SYNDROME 47
947 INCREASED TENDENCY TO BRUISE 47
948 LACERATION 47
949 LYMPHOEDEMA 47
950 MIOSIS 47
951 NO THERAPEUTIC RESPONSE 47
952 ORAL DISCOMFORT 47
953 PARANOIA 47
954 RENAL PAIN 47
955 SLUGGISHNESS 47
956 ALCOHOL POISONING 46
957 BEDRIDDEN 46
958 CATHETERISATION CARDIAC 46
959 DIZZINESS POSTURAL 46
960 INCREASED APPETITE 46
961 INFUSION SITE INFECTION 46
962 LIVER FUNCTION TEST INCREASED 46
963 RIGHT VENTRICULAR FAILURE 46
964 UMBILICAL HERNIA 46
965 BLOOD ALBUMIN DECREASED 45
966 CEREBRAL INFARCTION 45
967 CORNEAL OEDEMA 45
968 GLOSSODYNIA 45
969 HAEMATOLOGICAL INFECTION 45
970 HYPOVOLAEMIA 45
971 INCONTINENCE 45
972 INFECTED BITE 45
973 INFUSION SITE OEDEMA 45
974 INJECTION SITE SCAR 45
975 ORTHOSTATIC HYPOTENSION 45
976 PARKINSON^S DISEASE 45
977 PELVIC FRACTURE 45
978 PRODUCT PRESCRIBING ERROR 45
979 PROSTATE CANCER 45
980 SINUSITIS BACTERIAL 45
981 SKIN NECROSIS 45
982 SNORING 45
983 CONTRAINDICATED PRODUCT ADMINISTERED 44
984 INJECTION SITE ANAESTHESIA 44
985 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 44
986 LIGAMENT RUPTURE 44
987 SKIN WARM 44
988 THINKING ABNORMAL 44
989 TRANSFUSION 44
990 VIRAL UPPER RESPIRATORY TRACT INFECTION 44
991 ATRIOVENTRICULAR BLOCK COMPLETE 43
992 ATTENTION DEFICIT HYPERACTIVITY DISORDER 43
993 BLOOD LACTATE DEHYDROGENASE INCREASED 43
994 DRY THROAT 43
995 ENDOMETRIOSIS 43
996 GANGRENE 43
997 JOINT RANGE OF MOTION DECREASED 43
998 MALNUTRITION 43
999 MONOCYTE COUNT INCREASED 43